Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$123.8 - $132.96 $204 Million - $219 Million
-1,649,500 Reduced 86.23%
263,400 $32.6 Million
Q1 2024

May 10, 2024

BUY
$113.24 - $131.95 $217 Million - $252 Million
1,912,900 New
1,912,900 $252 Million
Q2 2023

Aug 11, 2023

BUY
$108.61 - $118.38 $51.7 Million - $56.3 Million
476,000 New
476,000 $54.9 Million
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $24.5 Million - $31.4 Million
280,000 New
280,000 $31.1 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.